The AEMD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEMD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AEMD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AEMD Detailed Price Forecast - CNN Money||View AEMD Detailed Summary - Google Finance|
|View AEMD Detailed Summary - Yahoo! Finance||View AEMD Stock Research & Analysis - Zacks.com|
|View AEMD Trends & Analysis - Trade-Ideas||View AEMD Major Holders - Barrons|
|View AEMD Call Transcripts - NASDAQ||View AEMD Breaking News & Analysis - Seeking Alpha|
|View AEMD Annual Report - CompanySpotlight.com||View AEMD OTC Short Report - OTCShortReport.com|
|View AEMD Fundamentals - TradeKing||View AEMD SEC Filings - Bar Chart|
|View Historical Prices for AEMD - The WSJ||View Performance/Total Return for AEMD - Morningstar|
|View the Analyst Estimates for AEMD - MarketWatch||View the Earnings History for AEMD - CNBC|
|View the AEMD Earnings - StockMarketWatch||View AEMD Buy or Sell Recommendations - MacroAxis|
|View the AEMD Bullish Patterns - American Bulls||View AEMD Short Pain Metrics - ShortPainBot.com|
|View AEMD Stock Mentions - StockTwits||View AEMD Stock Mentions - PennyStockTweets|
|View AEMD Stock Mentions - Twitter||View AEMD Investment Forum News - Investor Hub|
|View AEMD Stock Mentions - Yahoo! Message Board||View AEMD Stock Mentions - Seeking Alpha|
|View Insider Transactions for AEMD - SECform4.com||View Insider Transactions for AEMD - Insider Cow|
|View AEMD Major Holdings Summary - CNBC||View Insider Disclosure for AEMD - OTC Markets|
|View Insider Transactions for AEMD - Yahoo! Finance||View Institutional Holdings for AEMD - NASDAQ|
|View AEMD Stock Insight & Charts - FinViz.com||View AEMD Investment Charts - StockCharts.com|
|View AEMD Stock Overview & Charts - BarChart||View AEMD User Generated Charts - Trading View|
Aethlon Medical Receives National Cancer Institute Award
Posted on Tuesday September 18, 2018
The Aethlon Hemopurifier is a first-in-class therapeutic technology designed for the rapid depletion of circulating viruses and cancer promoting exosomes. The FDA has designated the Hemopurifier as a "Breakthrough Device" for the treatment of life-threatening viruses for which there are no approved therapies.
AEMD: Compassionate Use, Real-World Data, Awaiting FDA Final Guidance
Posted on Tuesday August 28, 2018
Revenue of $150k represented the final payment from the phase I NCI cancer grant. A subsequent, phase 2 contract worth approximately $1.5M over two years, could follow – AEMD’s application for which is expected to be submitted later this year. Updates to several of the development programs were provided on the call, including that related to Hemopurifier under the Breakthrough Device designation, Hemopurifier’s potential role in cancer therapy and updates in the ESI segment – including CTE/TauSome study enrollment status and potential new opportunities.
Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Monday August 27, 2018
NEW YORK, Aug. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ball ...
Aethlon Medical Announces First Quarter Fiscal Year 2019 Results
Posted on Wednesday August 08, 2018
SAN DIEGO , Aug. 8, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal ...